Showing results (51-60 of 223) with videos related to
Sort By:
Pageof 23
Clinical Nephrology|January 25, 2006
Conservative treatment of renal angiomyolipomas in patients with tuberous sclerosisD A Hadley, L J Bryant, H C RuckleHepatology (Baltimore, Md.)|July 1, 1988
Influence of male hormones on rates of ethanol elimination in manE Mezey, J E Oesterling, J J PotterGeriatrics|March 25, 1998
Benign prostatic hyperplasia: use of drug therapy in primary careR Beduschi, M C Beduschi, J E OesterlingThe Urologic Clinics of North America|May 1, 1997
Molecular forms of serum prostate-specific antigen. The clinical value of percent free prostate-specific antigenP A Abrahamsson, H Lilja, J E OesterlingWorld Journal of Urology|January 1, 1997
Stage T1c prostate cancer: defining the appropriate staging evaluation and the role for pelvic lymphadenectomyM C Beduschi, R Beduschi, J E OesterlingUrology|June 3, 1998
Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha1A-adrenergic antagonistM C Beduschi, R Beduschi, J E OesterlingThe Journal of Urology|April 1, 1986
Xeroradiography and ultrasonography in the evaluation of a penile injuryJ E Oesterling, W D Bromberg, P C AlbertsenThe Journal of Urology|May 1, 1994
Prostate specific antigen cannot distinguish stage T1a (A1) prostate cancer from benign prostatic hyperplasiaJ M Monda, M J Barry, J E OesterlingEuropean Urology|January 1, 1994
Serum prostate-specific antigen discriminates weakly between men with benign prostatic hyperplasia and patients with organ-confined prostate cancerP D Sershon, M J Barry, J E OesterlingPageof 23